Status:
COMPLETED
A Controlled Smoking Cessation Trial and Prospective Cohort Study of Tuberculosis (TB) Treatment Outcomes
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
Global Fund
National Tuberculosis Control Program, Pakistan
Conditions:
Smoking Cessation
Tuberculosis
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
The primary focus of this intervention trial is to understand the effect of quitting smoking on TB treatment outcomes. The investigators will compare a cessation strategy based on guidelines recommend...
Eligibility Criteria
Inclusion
- Males, ≥18 years of age
- diagnosed with pulmonary TB
- self-reported current smokers, or smoker within 6 months
- anticipated to be attending the TB treatment clinic for at least 6 months
- be willing to set a quit date within 2 weeks after baseline assessment
- agree to participate
Exclusion
- less than 18 years of age
- quit for more than 6 months
- extra-pulmonary TB
- unable/unwilling to provide written consent
Key Trial Info
Start Date :
May 25 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2018
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT02238405
Start Date
May 25 2015
End Date
January 1 2018
Last Update
August 9 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Indus Hospital
Karachi, Pakistan